Monoclonal antibody and chemotherapy regimen

This page covers all Monoclonal antibody and chemotherapy regimen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD20.

Targets

CD20

Phase 3 pipeline (1)

• Rituximab plus CHOP · Sinocelltech Ltd. · Oncology
  Rituximab targets CD20 on B cells, while CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) is a chemotherapy regimen.